Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II

B Lankat-Buttgereit1, C Gregel, A Knolle

  • 1Clinical Research Unit for Gastrointestinal Endocrinology, University of Marburg, Baldingerstrasse, 35033 Marburg, Germany.

Insights

Programmed cell death 4 (pdcd4) suppresses endocrine tumor cell growth by inhibiting carbonic anhydrase II. Carbonic anhydrase inhibitors show promise for anti-endocrine tumor therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Programmed cell death 4 (pdcd4) is a newly identified gene upregulated during apoptosis.
  • Pdcd4 exhibits tumor suppressor activity and interacts with eukaryotic initiation factor 4A (eIF4A) to inhibit protein synthesis.
  • Tumor cell proliferation relies on high bicarbonate flux, which is regulated by carbonic anhydrase.

Purpose of the Study:

  • To investigate the role of pdcd4 in regulating carbonic anhydrase II expression.
  • To determine the effect of pdcd4-mediated carbonic anhydrase suppression on endocrine tumor cell growth.
  • To evaluate the therapeutic potential of carbonic anhydrase inhibitors in endocrine tumors.

Main Methods:

  • Cloning of rat pdcd4.
  • Analysis of pdcd4's effect on carbonic anhydrase type II protein expression in HEK293 and Bon-1 carcinoid cells.
  • Assessment of ethoxyzolamide's effect on endocrine tumor cell line growth.

Main Results:

  • Pdcd4 was shown to suppress carbonic anhydrase type II protein expression in HEK293 and Bon-1 carcinoid cells.
  • Suppression of carbonic anhydrase by pdcd4 led to growth inhibition of these tumor cells.
  • The carbonic anhydrase inhibitor ethoxyzolamide demonstrated reduced growth in several endocrine tumor cell lines.

Conclusions:

  • The translation inhibitor pdcd4 represses endocrine tumor cell growth through the suppression of carbonic anhydrase II.
  • Carbonic anhydrase inhibitors may serve as a promising therapeutic strategy for endocrine tumors.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...